Caladrius Biosciences Inc (NASDAQ:CLBS) Shorts Decreased By 55.87% As Of Apr 16, 2018

April 16, 2018 - By Kyle Williams

Change of 55.87% for Caladrius Biosciences Inc (NASDAQ:CLBS)’s short interest was showed. FINRA issued in April CLBS’s total 10,900 short interest. The 24,700 previous shares are down with 55.87%. With Average volume 44,400, CLBS’s previous position will take 0 days to recover.

On during the last trading session the stock decreased $0.01 or 0.10%, reaching $4.94.Caladrius Biosciences, Inc. has volume of 1,630 shares. Since April 16, 2017 CLBS has risen 20.65% and is uptrending. CLBS outperformed the S&P 500 by 9.10%.

Caladrius Biosciences, Inc. (NASDAQ:CLBS) Ratings Coverage

In total 2 analysts cover Caladrius Biosciences (NASDAQ:CLBS). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 5 are the (NASDAQ:CLBS)’s analyst reports since November 10, 2017 according to StockzIntelligence Inc. In Tuesday, March 6 report H.C. Wainwright maintained the stock with “Buy” rating. In Wednesday, March 14 report H.C. Wainwright maintained it with “Buy” rating and $12.0 target. On Friday, March 23 the stock has “Buy” rating by Chardan Capital Markets. On Friday, January 19 the rating was maintained by H.C. Wainwright with “Buy”. On Friday, November 10 the firm has “Buy” rating by H.C. Wainwright given.

Caladrius Biosciences, Inc. (NASDAQ:CLBS) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: